FDA NEWS

Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of - MSN MoneyCentral
ABBOTT PARK, Ill. and WILMINGTON, Del. , Aug. 14 /PRNewswire-FirstCall/ -- Abbott ( NYSE: ABT ) and AstraZeneca AZN announced today that they have entered into an agreement for Abbott to promote AstraZeneca's CRESTOR(R) (rosuvastatin calcium), a
Source: news.moneycentral.msn.com

Official: China food regulator's death accidental - San Diego Union-Tribune
BEIJING – The head of China's food safety watchdog has died in an accident, an official said Wednesday, amid a probe into his financial status. A spokeswoman for the agency said Wu Jianping died after falling from a building in an accident on Aug
Source: www.signonsandiego.com

LegalView Launches Viapro Drug Recall Site Due to Dangerous Ingredient - Transworld News
LegalView, the number one resource for everything and anything legal on the Web, recently launched a new information portal informing readers of a drug recall that could cause serious side effects to its patients. Viapro, from EG Labs, was
Source: www.transworldnews.com

Abbott faces more litigation over AIDS drug - Associated Press
SAN FRANCISCO (AP) -- When Abbott Laboratories Inc. hiked up the price of a popular AIDS drug by 400 percent in 2003, executives prepared for the inevitable public relations hit, but assured themselves the backlash would be brief. Nearly five years
Source: hosted.ap.org

Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal - Forbes
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company's fiscal 2009 sales and earnings estimates. Based on the Company's business planning and budgeting activities for
Source: www.forbes.com

ARCA biopharma Appoints William R. Hiatt as Director of Clinical and - MSN MoneyCentral
BROOMFIELD, Colo. , Aug. 14 /PRNewswire/ -- ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, announced today that it has appointed William R. Hiatt , MD
Source: news.moneycentral.msn.com

Boston Scientific Stent Study Flawed - Wall Street Journal
A heart stent manufactured by Boston Scientific Corp. and expecting approval for U.S. sales is backed by flawed research despite the company's claims of success in a clinical trial, according to a Wall Street Journal review of the data. Boston
Source: online.wsj.com